Góth László, Vitai Márta, Rass Péter, Sükei Eszter, Páy Anikó
Department of Clinical Biochemistry, Molecular Pathology, and Clinical Analytical Chemistry, University of Debrecen, Medical and Health Science Center, H-4012 Debrecen, Hungary.
Electrophoresis. 2005 May;26(9):1646-9. doi: 10.1002/elps.200410384.
The enzyme catalase is the main regulator of hydrogen peroxide metabolism. Recent findings suggest that a low concentration of hydrogen peroxide may act as a messenger in some signalling pathways whereas high concentrations are toxic for many cells and cell components. Acatalasemia is a genetically heterogeneous condition with a worldwide distribution. Yet only two Japanese and three Hungarian syndrome-causing mutations have been reported. A large-scale (23 130 subjects) catalase screening program in Hungary yielded 12 hypocatalasemic families. The V family with four hypocatalasemics (60.6 +/- 7.6 MU/L) and six normocatalasemic (103.6 +/- 23.5 MU/L) members was examined to define the mutation causing the syndrome. Mutation screening yielded four novel polymorphisms. Of these, three intron sequence variations, namely G-->A at the nucleotide 60 position in intron 1, T-->A at position 11 in intron 2, and G-->T at position 31 in intron 12, are unlikely to be responsible for the decreased blood catalase activity. However, the novel G-->A mutation in exon 9 changes the essential amino acid Arg 354 to Cys 354 and may indeed be responsible for the decreased catalase activity. This inherited catalase deficiency, by inducing an increased hydrogen peroxide steady-state concentration in vivo, may be involved in the early manifestation of type 2 diabetes mellitus for the 35-year old proband.
过氧化氢酶是过氧化氢代谢的主要调节因子。最近的研究结果表明,低浓度的过氧化氢可能在某些信号通路中充当信使,而高浓度的过氧化氢对许多细胞和细胞成分有毒性。无过氧化氢酶血症是一种遗传异质性疾病,在全球范围内均有分布。然而,仅报道了两例日本人和三例匈牙利人的致病综合征突变。在匈牙利进行的一项大规模(23130名受试者)过氧化氢酶筛查项目发现了12个过氧化氢酶血症偏低的家族。对一个V家族进行了检测,该家族有4名过氧化氢酶血症偏低者(60.6±7.6 MU/L)和6名过氧化氢酶水平正常者(103.6±23.5 MU/L),以确定导致该综合征的突变。突变筛查发现了4种新的多态性。其中,3种内含子序列变异,即内含子1中第60位核苷酸由G突变为A、内含子2中第11位由T突变为A以及内含子12中第31位由G突变为T,不太可能是导致血液过氧化氢酶活性降低的原因。然而,外显子9中的新G→A突变将必需氨基酸精氨酸354变为半胱氨酸354,可能确实是导致过氧化氢酶活性降低的原因。这种遗传性过氧化氢酶缺乏通过在体内诱导过氧化氢稳态浓度升高,可能与这位35岁先证者2型糖尿病的早期表现有关。